Unknown

Dataset Information

0

Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment.


ABSTRACT:

SUBMITTER: Lv J 

PROVIDER: S-EPMC8152428 | biostudies-literature | 2021 May-Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment.

Lv Jialu J   Lin Jianqing J  

Asian journal of andrology 20210501 3


Similar Datasets

| S-EPMC4667159 | biostudies-literature
| S-EPMC8218467 | biostudies-literature
| S-EPMC8967300 | biostudies-literature
| S-EPMC10198864 | biostudies-literature
| S-EPMC6215908 | biostudies-literature
| S-EPMC8366106 | biostudies-literature
| S-EPMC10102515 | biostudies-literature
| S-EPMC9254324 | biostudies-literature
| S-EPMC7012296 | biostudies-literature
| S-EPMC10191952 | biostudies-literature